Search Results
Results found for "Nobel Prize"
- 📰 GPCR Weekly News - January 2 to 8, 2023
Progressive Technologies and Approaches Revealing Novel GPCR Biology and Drug Development Potential. Investigation Of The Role Of The Formyl Peptide Receptor 2 In Diabetic Retinopathy PhD Opportunity - Novel
- Synthesis and characterization of an orally bioavailable small molecule agonist of the apelin recept
Previously, we had identified a novel pyrazole-based agonist 1 ((S)-N-(1-(cyclobutylamino)-1-oxo-5-(piperidin
- Molecular basis for ligand modulation of the cannabinoid CB 1 receptor
These advances have paved the way for development of novel ligands for different therapeutic applications
- Trevena Announces Receipt of First $15 million Tranche in Connection with its $40 million ...
(Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel
- 📰 GPCR Weekly News
Phenotypic screen identifies the natural product silymarin as a novel anti-inflammatory analgesic. Progressive Technologies and Approaches Revealing Novel GPCR Biology and Drug Development Potential.
- 🤯Mind-blowing GPCR Scoops! Discover the Latest Breakthroughs! ⦿ Nov 18 - 24, 2024
GPCR University 🎥 Recorded GPCR Courses and Symposia / Summit 💲 Special Pricing on GPCR courses Receptor Type 2 (NTS2) Opioid-Free Analgesics GPCRs in Cardiology, Endocrinology, and Taste Elucidating novel
- Dr. GPCR University registration is now open! Secure your spot now!
Downstream Proteins Indicates Biased Signal Transduction Pathways Activation of a GPCR, ORL1 receptor: A novel cells Industry News Confo Therapeutics Announces EUR 60M Series B Financing to Advance a Pipeline of Novel
- High hedgehog signaling is transduced by a multikinase-dependent switch controlling the...
these results link the morphogenetic effects of HH to the apico-basal distribution of SMO and provide a novel
- Reversible Photocontrol of Dopaminergic Transmission in Wild-Type Animals
Here, we introduce azodopa, a novel photoswitchable ligand that enables reversible spatiotemporal control
- Adenosine receptor signalling in Alzheimer's disease
available medicines targeting these receptors approved for treating dementia, we provide insights into some novel
- Adenosine receptor signalling in Alzheimer's disease
available medicines targeting these receptors approved for treating dementia, we provide insights into some novel
- Crinetics Pharmaceuticals Expands Executive Team With Appointment Of James Hassard As Chief ...
clinical stage pharmaceutical company focused on the discovery, development, and commercialization of novel
- 📰 GPCR Weekly News, June 24 to 30, 2024
Let’s dive into the Classified GPCR News from June 24th to 30th, 2024 Adhesion GPCRs Novel Isoforms of Disease-Associated GαS Variants Characterized by an Integrative Biophysical Approach Redox-modulated SNX25 as a novel
- Exscientia is 10 years old this July!
Founded as a spinout from the University of Dundee on 20 July 2012, Exscientia pioneered the design of novel
- 📢 Early Bird Registration Ends Tomorrow! | Sep 16 - 22, 2024
Become a Premium Member to access both courses at a reduced price. Favorable Phase 1a Safety, Tolerability and PK/PD Results for Lead Program TX45 Adenosine A2a receptor: novel
- PLC-IP3-ORAI pathway participates in the activation of the MRGPRB2 receptor in mouse peritoneal...
ORAI pathway participates in the activation of the MRGPRB2 receptor in mouse peritoneal mast cells "A novel
- Pharmacology at Your Fingertips: Terry’s Corner Launches
must-read chemokine and PTH1R papers, and new momentum across biotech—from Superluminal to Neurocrine to novel
- Trevena Adds Seasoned Biopharma Commercial Executive to Senior Leadership Team
(Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel
- Nanobodies as Probes and Modulators of Cardiovascular G Protein-Coupled Receptors
As a result, there is an ongoing need to develop novel approaches to monitor and to modulate GPCR activation
- Membrane Lipids Are an Integral Part of Transmembrane Allosteric Sites in GPCRs: A Case Study of...
Modulator, ORG27569, and Analogs "A growing number of G-protein-coupled receptor (GPCR) structures reveal novel
- Dopamine D 1 receptor-mediated β-arrestin signaling: Insight from pharmacology, biology, behavior...
selectivity/biased signaling has led to the discovery of biased compounds as both research tools and novel
- Orion Shares New Data on its Latest Best-in-Class Drug Candidate
Oliver Hartley, Orion’s Vice-President Drug Discovery, will present Orion’s novel technology for targeting
- Orion Announces The Rapid Lead Optimization Of Ob-004 - A Ccr2 Antagonist
clinical stage company unlocking the therapeutic potential of G Protein-Coupled Receptors (GPCRs) with a novel
- 📰 GPCR Weekly News - January 9 to 15, 2023
Progressive Technologies and Approaches Revealing Novel GPCR Biology and Drug Development Potential. Investigation Of The Role Of The Formyl Peptide Receptor 2 In Diabetic Retinopathy PhD Opportunity - Novel
- Addex and Indivior Extend GABAB Positive Allosteric Modulator Research Collaboration for...
announced that its collaboration agreement with Indivior PLC (LON: INDV) for discovering and developing novel
- California gold rush for Sosei Heptares
The vision is to develop novel muscarinic receptor agonists for schizophrenia and other neuropsychiatric
- VIB spin-off Confo Therapeutics Enters Collaborative Agreement with Regeneron
receptors) in disease-relevant conformations, will be applied with the goal of enabling the discovery of novel
- GPCR Agonist-to-Antagonist Conversion: Enabling the Design of Nucleoside Functional Switches for...
We synthesized and characterized a novel A2AAR antagonist, 2 (LJ-4517), with Ki = 18.3 nM.
- Helix 8 in chemotactic receptors of the complement system
Orthosteric and allosteric antagonists of C5aR1 are a novel strategy for anti-inflammatory therapies.
- 📰 GPCR Weekly News, February 13 to 19, 2023
GPCR Binders, Drugs, and more Novel targets for potential therapeutic use in Diabetes mellitus. Progressive Technologies and Approaches Revealing Novel GPCR Biology and Drug Development Potential.






